References
- Kanerva M, Moilanen K, Virolainen S, et al. Melkersson-Rosenthal syndrome. Otolaryngol Head Neck Surg. 2008;138:246–251.
- Wehl G, Rauchenzauner M. A systematic review of the literature of the three related disease entities cheilitis granulomatosa, orofacial granulomatosis and Melkersson-Rosenthal syndrome. Curr Pediatr Rev. 2018;14(3):196–203.
- Greene RM, Rogers RS 3rd. Melkersson-Rosenthal syndrome: a review of 36 patients. J Am Acad Dermatol. 1989;21:1263–1270.
- Hornstein OP, Stosiek N, Schonberger A, et al. Classification and scope of clinical variations of Melkersson-Rosenthal syndrome. Z Hautkr. 1987;62:1453–1466. 1471-5.
- Wiesenfeld D, Ferguson MM, Mitchell DN, et al. Oro-facial granulomatosis-a clinical and pathological analysis. Q J Med. 1985;54:101–113.
- Haaramo A, Alapulli H, Aine L, et al. Detailed follow-up study of pediatric orofacial granulomatosis patients. J Pediatr Gastroenterol Nutr. 2017;65:388–393.
- Basu MK, Asquith P, Thompson RA, et al. Proceedings: oral lesions in patients with Crohn's disease. Gut 1974;15:346.
- Tyldesley WR. Oral Crohn's disease and related conditions. Br J Oral Surg. 1979;17:1–9.
- Challacombe SJ. Oro-facial granulomatosis and oral Crohns disease: are they specific diseases and do they predict systemic Crohns disease? Oral Dis. 2008;3:127–129.
- Sanderson J, Nunes C, Escudier M, et al. Oro-facial granulomatosis: Crohn's disease or a new inflammatory bowel disease? Inflamm Bowel Dis. 2005;11:840–846.
- Tilakaratne WM, Freysdottir J, Fortune F. Orofacial granulomatosis: review on aetiology and pathogenesis. J Oral Pathol Med. 2008;37:191–195.
- Grave B, McCullough M, Wiesenfeld D. Orofacial granulomatosis-a 20-year review. Oral Dis. 2009;15:46–51.
- Freysdottir J, Zhang S, Tilakaratne WM, et al. Oral biopsies from patients with orofacial granulomatosis with histology resembling Crohn's disease have a prominent Th1 environment. Inflamm Bowel Dis. 2007;13:439–445.
- Miest R, Bruce A, Rogers RS. 3rd,. Orofacial granulomatosis. Clin Dermatol. 2016;34:505–513.
- Kolho KL, Raivio T, Lindahl H, et al. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease. Scand J Gastroenterol. 2006;41:720–725.
- Hamalainen A, Sipponen T, Kolho KL. Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels. World J Gastroenterol. 2011;17:5166–5171.
- Haaramo A, Alapulli H, Aine L, et al. Oral and otorhinolaryngological findings in adults who were diagnosed with pediatric onset Crohn's disease: a controlled study. J Clin Gastroenterol. 2018. DOI:https://doi.org/10.1097/MCG.0000000000001074
- Worsaae N, Christensen KC, Schiodt M, et al. Crohn's disease in the oral cavity. Ugeskr Laeger. 1980;142:2701–2704.